Literature DB >> 9074856

Pathophysiology and treatment implications of hypertension in the African-American population.

M Rahman1, J G Douglas, J T Wright.   

Abstract

Regardless of the etiology, hypertension remains a major public health problem in African-Americans and is associated with significant morbidity and mortality. Additional data on the pathophysiology of this disease in this population are needed, as are data on the best therapies to decrease the high complication rate. Because many of the large studies on hypertension have included few African-Americans, recruitment of this ethnic group into clinical trials should be promoted. Further studies into the genetic factors in the pathophysiology of racial differences in hypertension may shed more light on this complex issue.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9074856     DOI: 10.1016/s0889-8529(05)70237-1

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  15 in total

1.  Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.

Authors:  Yuqing Chen; Michael S Lipkowitz; Rany M Salem; Maple M Fung; Vibha Bhatnagar; Manjula Mahata; Caroline M Nievergelt; Fangwen Rao; Sushil K Mahata; Nicholas J Schork; Pamela J Hicks; Donald W Bowden; Barry I Freedman; Victoria H Brophy; Daniel T O'Connor
Journal:  Am J Nephrol       Date:  2010-05-19       Impact factor: 3.754

2.  Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups.

Authors:  Elizabeth O Ofili; Suzanne Oparil; Thomas Giles; Bertram Pitt; Das Purkayastha; Robert Hilkert; Rita Samuel; James R Sowers
Journal:  J Am Soc Hypertens       Date:  2011-04-08

3.  Treatment of the African-American patient with congestive heart failure.

Authors:  Sandeep A Kamath; Clyde W Yancy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

Review 4.  Nephropathy in youth and young adults with type 2 diabetes.

Authors:  Carolina Solis-Herrera; Curtis L Triplitt; Jane L Lynch
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

5.  Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.

Authors:  José-Miguel Yamal; Suzanne Oparil; Barry R Davis; Michael H Alderman; David A Calhoun; William C Cushman; Herbert F Fendley; Stanley S Franklin; Gabriel B Habib; Sara L Pressel; Jeffrey L Probstfield; Sithiporn Sastrasinh
Journal:  J Am Soc Hypertens       Date:  2014-08-19

6.  A model of psychosocial and cultural antecedents of blood pressure control.

Authors:  Hayden B Bosworth; Eugene Z Oddone
Journal:  J Natl Med Assoc       Date:  2002-04       Impact factor: 1.798

7.  Hypertension in women: latest findings and clinical implications.

Authors:  Helga Gudmundsdottir; Aud Høieggen; Aud Stenehjem; Bård Waldum; Ingrid Os
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

8.  Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).

Authors:  Jennifer J Gassman; Tom Greene; Jackson T Wright; Lawrence Agodoa; George Bakris; Gerald J Beck; Janice Douglas; Ken Jamerson; Julia Lewis; Michael Kutner; Otelio S Randall; Shin-Ru Wang
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

9.  Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis.

Authors:  Maple M Fung; Yuqing Chen; Michael S Lipkowitz; Rany M Salem; Vibha Bhatnagar; Manjula Mahata; Caroline M Nievergelt; Fangwen Rao; Sushil K Mahata; Nicholas J Schork; Victoria H Brophy; Daniel T O'Connor
Journal:  Nephrol Dial Transplant       Date:  2009-09-10       Impact factor: 5.992

10.  Hemodynamic and echocardiographic profiles in African American compared with White offspring of hypertensive parents: the HyperGEN study.

Authors:  Stephen P Glasser; Amy I Lynch; Richard B Devereux; Paul Hopkins; Donna K Arnett
Journal:  Am J Hypertens       Date:  2013-11-16       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.